RAPH Share Price Performance
US$1.00
0.60 (150.00%)
Price US$1.00
Share Pricen/a
Raphael Pharmaceutical Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
RAPH Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
Raphael Pharmaceutical Inc. Key Details
About RAPH
- Founded
- n/a
- Employees
- n/a
- CEO
- WebsiteView website
Raphael Pharmaceutical Inc., a pharmaceutical drug research and development company, focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids. The company develops lead product candidate for the treatment of rheumatoid arthritis. It also intends to develop cannabinoid-based drug products for the treatment of oncology indications and other autoimmune diseases. The company is headquartered in Tel Aviv-Jaffa, Israel.
